serinatherapeutics.com (SER): Net earnings per share growth forecast for next year

Graphic logo of Serina (SER)

The development of Serina Therapeutics, Inc. (SER) relies on the success of clinical trials and patent protection. The estimated EPS growth for the coming year shows a peak, after which the 29.10 level captures the current state. The company's strong pricing power is based on low-toxicity molecule delivery to the brain. The business is currently scaling its Parkinson's disease therapy, ensuring stable drug efficacy.

Serina Therapeutics Inc (SER): Expected net earnings per share growth next year from 03/28/2024 to 11/18/2026

Metric breakdowns and analytics for Serina Therapeutics Inc (SER)

Initial company analysis:Serina Therapeutics Inc, SER
Brand item of Serina Therapeutics

For Serina Therapeutics, Inc. (SER), the potential for royalty payments from the POZ platform directly determines future profitability, which is reflected in the consensus earnings forecast for the coming year. This indicator measures the percentage change in expected earnings per share, capturing real-time revisions to analyst models. By analyzing the historical trend of the n+1 earnings forecast, an investor assesses the stability of fundamental expectations, where any sharp reversal signals risks of failing to meet business targets.

Competitors of Serina Therapeutics, Inc.

Net earnings per share growth forecast for next year Jazz Pharmaceuticals|CYTK: Expected earnings per share trend next year|Net earnings per share growth forecast for next year PTC Bio (PTCT)|SRRK - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Expected net earnings per share growth next year|EWTX - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Rapport Therapeutics, Inc.|ALMS: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Kempharm ZVRA|Expected earnings per share growth for next year CTNM|Expected net earnings per share growth next year Larimar Corp LRMR|Earnings growth forecast for next year CAPR|TRDA - Expected net earnings per share growth next year|Earnings growth forecast for next year PTHS (Channel Therapeutics Corp)|MediciNova Corp (MNOV) - Expected net earnings per share growth next year|BTAI - Net earnings per share growth forecast for next year|promisneurosciences.com (PMN) - Expected earnings per share growth for next year|Apimeds (APUS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AEON|Net earnings per share growth forecast for next year NLS Pharma|Expected net earnings per share growth next year bionomics.com.au BNOX|Earnings growth forecast for next year HUGE|RETA (Reata Pharma) - Expected earnings per share trend next year